Skip to content

Tailored Asthma Management for Urban Teens

Tailored Asthma Management for Urban Teens

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00201058
Acronym
Puff City
Enrollment
450
Registered
2005-09-20
Start date
2006-07-31
Completion date
2010-06-30
Last updated
2012-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

urban, adolescents, African American, web-based, computer tailoring, school based

Brief summary

The purpose of this project is to refine and further evaluate an online asthma management and education program for urban teenagers. This project is a continuation of Puff City I, a project piloting and evaluating a tailored, school-based, computerized asthma education program for urban teenagers. In this second phase of research, a new version of software (Puff City II) will be created that will target resistance to change and relapse, and using a tested, theory-based approach to student recruitment, conduct a randomized trial to test the efficacy of this new software.

Detailed description

BACKGROUND: Teenagers are among an age group that has seen dramatic increases in deaths from asthma. In Detroit, asthma death rates for teenagers are high relative to younger ages, despite a higher prevalence in the latter age group. Early studies suggest that inadequate asthma management plays a significant role in these grim statistics. DESIGN NARRATIVE: The study hypothesis is that students randomized to the intervention group will have lower asthma-related morbidity as determined by fewer emergency department visits and hospitalizations at the time of the 12-month follow-up. Based on a second hypothesis of better functional status among students randomized to the intervention group, secondary outcomes include fewer symptom-days, symptom-nights, school days missed, and days of restricted activity at the time of the 12-month follow-up. In addition, it is hypothesized that students in the intervention group will have higher scores on the Juniper Pediatric Quality of Life scale at 12 months. Finally, it is hypothesized that intervention students would exhibit positive changes in adherence behavior, having a rescue inhaler nearby, and smoking at the 12-month follow-up.

Interventions

BEHAVIORALTailored Web-based Asthma Management

Web-based asthma management

BEHAVIORALGeneric web-based asthma education

4 computer sessions over a period of 180 days

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Henry Ford Health System
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* A physician diagnosis of asthma AND recent asthma symptoms, health care utilization for asthma, and/or use of medication (or refills of medication) to alleviate asthma symptoms OR * No physician diagnosis of asthma AND positive responses to items selected from the International Study of Asthma and Allergy in Children (ISAAC) survey AND asthma symptoms similar to those used in the Expert Panel II for classification of mild intermittent asthma

Exclusion criteria

* Does not meet asthma symptom criteria

Design outcomes

Primary

MeasureTime frame
Asthma-related morbidityMeasured at baseline, 6 months, and 12 months with the latter being the timepoint of interest

Secondary

MeasureTime frame
Symptom-daysMeasured at baseline, 6 months, and 12 months with the latter being the timepoint of interest
Symptom-nightsMeasured at baseline, 6 months, and 12 months with the latter being the timepoint of interest
School days missedMeasured at baseline, 6 months, and 12 months with the latter being the timepoint of interest
Days of restricted activityMeasured at baseline, 6 months, and 12 months with the latter being the timepoint of interest

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026